ArticleScientific reports2025

SEPT9 methylation as a diagnostic and predictive biomarker in the progression of ductal carcinoma in situ to invasive breast cancer.

Yuan Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.